Ahmad 
The University of Hong Kong announced the development of a new drug that targets nasopharyngeal cancer enabling it to stimulate cancer cells to self-destruct.
According to the statement issued by the university, the new drug, which is known to use mRNA technology, stimulates what is known as the “suicide mechanism” within cancer cells, leading to their self-death.
The research indicated that this type of cancer is closely linked to Epstein-Barr virus infection, which opens the door to using this drug to treat other types of cancers associated with this virus.
This development of the drug was the result of joint cooperation between the University of Hong Kong and the Jackson Laboratory in the United States and is an important step in the war against cancer.
Experiments conducted on mice showed promising results, as they demonstrated the effectiveness of the drug in eliminating cancer cells without negatively affecting the surrounding healthy cells, which could mean a revolution in the treatment of cancer with the least possible side effects.
mRNA technology is one of the advanced biological technologies that is used in several medical fields, including developing vaccines and treating genetic diseases and cancer.
This technology relies on the use of RNA molecules to stimulate cells to produce specific proteins that may be necessary to prevent or combat diseases.
An American investor criticizes Washington’s policies regarding Russian assets